Uncategorized
Omeros reports $15.1 million quarterly net loss
Omeros reported a net loss of $15.1 million, or $0.34 per share, in the first quarter of 2017 compared with a net loss of $20.5 million, or $0.54 per share, in the same quarter last year, according to a company press release.Total revenues were $12.3 million, which were all related to sales of Omidria (phenylephrine 1% and ketorolac 0.3% injection). In the same quarter of 2016, total revenues were $7.2 million from Omidria sales and $173,000 in grants.